Please Login to read the full article.
Clinica
Heart stent firms may be hit by unfavourable study showing drugs as good – and cheaper – in stable patients
29 February 2012
Madeleine Armstrong
Please Login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- St Jude halts FFR study earlier than expected on positive results
- Geron, Angiotech exit stem cell arena as funds dry up, but good news for Mesoblast
- TCT 2011: Boston's next-gen Promus Element succeeds in long lesions; Ion beats older-gen stents
- Stryker’s Wingspan clipped by study showing higher stroke risk versus drug therapy
Other Informa News
EVENTS
